Generation and Characterization of a Stable MK2-EGFP Cell Line and Subsequent Development of a High-Content Imaging Assay on the Cellomics ArrayScan Platform to Screen for p38 Mitogen-Activated Protein Kinase Inhibitors

Methods in Enzymology

Volumn 414, Issue , 2006, Pages 364-389

  Williams, Rhonda Gates ^a   Kandasamy, Ramani ^a   Nickischer, Debra ^a   Trask Jr , Oscar J ^a   Laethem, Carmen ^a   Johnston, Patricia A ^a   Johnston, Paul A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 5 (2,6 DICHLOROPHENYL) 2 (2,4 DIFLUOROPHENYLTHIO)PYRIMIDO[1,6 B]PYRIDAZIN 6 ONE; 6 AMINO 2 (4 FLUOROPHENYL) 4 METHOXY 3 (4 PYRIDYL) 1H PYRROLO[2,3 B]PYRIDINE; ANISOMYCIN; DIMETHYL SULFOXIDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; SB 242235; STAUROSPORINE; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; UO 126; WORTMANNIN;

ALGORITHM; CELL LINE; DRUG SCREENING; ENZYME ANALYSIS; HELA CELL; HUMAN; IMAGING SYSTEM; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RETROVIRUS INFECTION; REVIEW;

EID: 33750813639     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(06)14021-5     Document Type: Chapter

References (24)

1. Almholt D.L., Loechel F., Nielsen S.J., Krog-Jensen C., Terry R., Bjorn S.P., Pedersen H.C., Praestegaard M., Moller S., Heide M., Pagliaro L., Mason A.J., Butcher S., and Dahl S.W. Nuclear export inhibitors and kinase inhibitors identified using a MAPK-activated protein kinase 2 redistribution screen. Assay Drug Dev. Technol. 2 (2004) 7-20
2. Cowan K.J., and Storey K.B. Mitogen-activated protein kinases: New signaling pathways functioning in cellular responses to environmental stress. J. Exp. Biol. 206 (2003) 1107-1115
3. DeBiasio R., Bright G.R., Ernst L.A., Waggoner A.S., and Taylor D.L. Five-parameter fluorescence imaging: Wound healing of living Swiss 3T3 cells. J. Cell Biol. 105 (1987) 1613-1622
4. Engel K., Kotlyarov A., and Gaestel M. Leptomycin B-sensitive nuclear export of MAPKAP kinase 2 is regulated by phosphorylation. EMBO J. 17 (1998) 3363-3371
5. English J.M., and Cobb M.H. Pharmacological inhibitors of MAPK pathways. Trends Pharmacol. Sci. 23 (2002) 40-45
6. Fabbro D., Ruetz S., Buchdunger E., Cowan-Jacob S.W., Fendrich G., Liebetanz J., Mestan J., O'Reilly T., Traxler P., Chaudhuri B., Fretz H., Zimmermann J., Meyer T., Caravatti G., Furet P., and Manley P.W. Protein kinases as targets for anticancer agents: From inhibitors to useful drugs. Pharmacol. Ther. 93 (2002) 79-98
7. Garrington T.P., and Johnson G.L. Organization and regulation of mitogen activated protein kinase signaling pathways. Curr. Opin. Cell Biol. 11 (1999) 211-218
8. Giuliano K.A., DeBiasio R.L., Dunlay R.T., Gough A., Volosky J.M., Zock J., Pavlakis G.N., and Taylor D.L. High-content screening: A new approach to easing key bottlenecks in the drug discovery process. J. Biomol. Screen. 2 (1997) 249-259
9. Giuliano K.A., and Taylor D.L. Fluorescent-protein biosensors: New tools in drug discovery. TIBTech. 16 (1998) 135-140
10. Johnston P.A., and Johnston P.A. Cellular platforms for HTS: Three case studies. Drug Discov. Today 7 (2002) 353-363
11. Kotlyarov A., Neininger A., Schubert C., Eckert R., Birchmeier C., Volk H.D., and Gaestel M. MAPKAP kinase 2 is essential for LPS-induced TNF-alpha biosynthesis. Nature Cell Biol. 1 (1999) 94-97
12. Lundholt B.K., Linde V., Loechel F., Pedersen H.C., Moller S., Praestegaard M., Mikkelsen I., Scudder K., Bjorn S.P., Heide M., Arkhammar P.O., Terry R., and Nielsen S.J. Identification of Akt pathway inhibitors using redistribution screening on the FLIPR and the IN Cell 3000 analyzer. J. Biomol. Screen. 10 (2005) 20-29
13. Mitchison T.J. Small-molecule screening and profiling by using automated microscopy. Chembiochem. 6 (2005) 33-39
14. Neininger A., Kontoyiannis D., Kotlyarov A., Winzen R., Eckert R., Volk H.D., Holtmann H., Kollias G., and Gaestel M. MK2 targets AU-rich elements and regulates biosynthesis of tumor necrosis factor and interleukin-6 independently at different post-transcriptional levels. J. Biol. Chem. 277 (2002) 3065-3068
15. Neininger A., Thielemann H., and Gaestel M. FRET-based detection of different conformations of MK2. EMBO Rep. 2 (2001) 703-708
16. Noble M.E.M., Endicott J.A., and Johnson L.N. Protein kinase inhibitors: Insights into drug design and structure. Science 303 (2004) 1800-1805
17. Ono K., and Han J. The p38 signal transduction pathway, activation and function. Cell. Signal. 12 (2000) 1-13
18. Ramm P., Alexandrov Y., Cholewinski A., Cybuch Y., Nadon R., and Soltys B.J. Automated screening of neurite outgrowth. J. Biomol. Screen. 8 (2003) 7-18
19. Regan J., Breitfelder S., Cirillo P., Gilmore T., Graham A.G., Hickey E., Klaus B., Madwed J., Moriak M., Moss N., Pargellis C., Pav S., Proto A., Swinamer A., Tong L., and Torcellini C. Pyrazole urea-based inhibitors of p38 MAP kinase: From lead compound to clinical candidate. J. Med. Chem. 45 (2002) 2994-3008
20. Tavare J.M., Fletcher L.M., and Welsh G.I. Using green fluorescent protein to study intracellular signaling. J. Endocrinol. 170 (2001) 297-306
21. Thomas N., and Goodyer D. Stealth sensors: Real-time monitoring of the cell cycle. Targets 2 (2003) 26-33
22. Trask Jr. O.J., Baker A., Williams R.G., Kickischer D., Kandasamy R., Laethem C., Johnston P.A., and Johnston P.A. Assay development and case history of a 32K-biased library high-content MK2-EGFP translocation screen to identify p38 MAPK inhibitors on the ArrayScan 3.1 imaging platform. Methods Enzymol. 414 (2006) (this volume)
23. Zhang J.H., Chung T.D., and Oldenburg K.R. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J. Biomol. Screen. 4 (1999) 67-73
24. Zu Y.L., Ai Y., and Huang C.K. Characterization of an autoinhibitory domain in human mitogen-activated protein kinase-activated protein kinase 2. J. Biol. Chem. 270 (1995) 202-206